{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:38:40Z","timestamp":1785526720058,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":159,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-06009-9","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:40:22Z","timestamp":1766025622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-omics analysis reveals cell adhesion molecules as key regulators of immune cell infiltration and adverse outcomes and in vitro validation of CLDN16 in pancreatic adenocarcinoma"],"prefix":"10.1007","volume":"83","author":[{"given":"Zewei","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanpeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5416-6149","authenticated-orcid":false,"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"4","key":"6009_CR1","first-page":"271","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271\u2013289","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"6009_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"6009_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S2468-1253(16)30079-6","volume":"1","author":"FM Walter","year":"2016","unstructured":"Walter FM, Mills K, Mendonca SC, Abel GA, Basu B, Carroll N, Ballard S, Lancaster J, Hamilton W, Rubin GP, Emery JD (2016) Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study. Lancet Gastroenterol Hepatol 1(4):298\u2013306","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"6009_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00659-4","volume":"6","author":"S Wang","year":"2021","unstructured":"Wang S, Zheng Y, Yang F, Zhu L, Zhu XQ, Wang ZF, Wu XL, Zhou CH, Yan JY, Hu BY, Kong B, Fu DL, Bruns C, Zhao Y, Qin LX, Dong QZ (2021) The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduct Target Ther 6(1):249","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6009_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01623-z","volume":"16","author":"LK Godfrey","year":"2024","unstructured":"Godfrey LK, Forster J, Liffers ST, Schroder C, Koster J, Henschel L, Ludwig KU, Lahnemann D, Trajkovic-Arsic M, Behrens D, Scarpa A, Lawlor RT, Witzke KE, Sitek B, Johnsen SA, Rahmann S, Horsthemke B, Zeschnigk M, Siveke JT (2024) Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation. Clin Epigenetics 16(1):13","journal-title":"Clin Epigenetics"},{"issue":"8","key":"6009_CR6","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA (2023) Pasca Di Magliano, A. Maitra, pancreatic cancer: advances and challenges. Cell 186(8):1729\u20131754","journal-title":"Cell"},{"issue":"4","key":"6009_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/carcin\/bgu045","volume":"35","author":"E Farahani","year":"2014","unstructured":"Farahani E, Patra HK, Jangamreddy JR, Rashedi I, Kawalec M, Rao RK, Pariti P, Batakis E, Wiechec (2014) Cell adhesion molecules and their relation to (cancer) cell stemness. Carcinogenesis 35(4):747\u2013759","journal-title":"Carcinogenesis"},{"key":"6009_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01078","volume":"10","author":"H Harjunpaa","year":"2019","unstructured":"Harjunpaa H, Llort Asens M, Guenther C, Fagerholm SC (2019) Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol 10:1078","journal-title":"Front Immunol"},{"issue":"10","key":"6009_CR9","doi-asserted-by":"publisher","first-page":"e1008451","DOI":"10.1371\/journal.pgen.1008451","volume":"15","author":"A Olson","year":"2019","unstructured":"Olson A, Le V, Aldahl J, Yu EJ, Hooker E, He Y, Lee DH, Kim WK, Cardiff RD, Geradts J, Sun Z (2019) The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression. PLoS Genet 15(10):e1008451","journal-title":"PLoS Genet"},{"key":"6009_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101118","author":"CY Loh","year":"2019","unstructured":"Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, Chong PP, Looi CY (2019) The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. https:\/\/doi.org\/10.3390\/cells8101118","journal-title":"Cells"},{"issue":"1","key":"6009_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10555-007-9101-z","volume":"27","author":"IP Witz","year":"2008","unstructured":"Witz IP (2008) The selectin-selectin ligand axis in tumor progression. Cancer Metastasis Rev 27(1):19\u201330","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"6009_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/bjc.2017.411","volume":"118","author":"C Siret","year":"2018","unstructured":"Siret C, Dobric A, Martirosyan A, Terciolo C, Germain S, Bonier R, Dirami T, Dusetti N, Tomasini R, Rubis M, Garcia S, Iovanna J, Lombardo D, Rigot V, Andre F (2018) Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma. Br J Cancer 118(4):546\u2013557","journal-title":"Br J Cancer"},{"issue":"3","key":"6009_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/path.5320","volume":"249","author":"CS Reader","year":"2019","unstructured":"Reader CS, Vallath S, Steele CW, Haider S, Brentnall A, Desai A, Moore KM, Jamieson NB, Chang D, Bailey P, Scarpa A, Lawlor R, Chelala C, Keyse SM, Biankin A, Morton JP, Evans TJ, Barry ST, Sansom OJ, Kocher HM, Marshall JF (2019) The integrin alphavbeta6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. J Pathol 249(3):332\u2013342","journal-title":"J Pathol"},{"issue":"8","key":"6009_CR14","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.7150\/jca.39800","volume":"11","author":"M Cui","year":"2020","unstructured":"Cui M, You L, Zheng B, Huang X, Liu Q, Huang J, Pan B, Qiu X, Liao Q, Zhao Y (2020) High expression of cancer-derived glycosylated immunoglobulin G predicts poor prognosis in pancreatic ductal adenocarcinoma. J Cancer 11(8):2213\u20132221","journal-title":"J Cancer"},{"issue":"1","key":"6009_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13046-021-01946-2","volume":"40","author":"M Kemper","year":"2021","unstructured":"Kemper M, Schiecke A, Maar H, Nikulin S, Poloznikov A, Galatenko V, Tachezy M, Gebauer F, Lange T, Riecken K, Tonevitsky A, Aigner A, Izbicki J, Schumacher U, Wicklein D (2021) Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. J Exp Clin Cancer Res 40(1):214","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"6009_CR16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN (2010) ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26(12):1572\u20131573","journal-title":"Bioinformatics"},{"issue":"5","key":"6009_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287","journal-title":"OMICS"},{"key":"6009_CR18","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, Ramaswamy S, Futreal PA, Haber DA, Stratton MR, Benes C, McDermott U, Garnett MJ (2013) Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41:D955\u2013D961 (Database issue)","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"6009_CR19","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS (2014) pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One 9(9):e107468","journal-title":"PLoS One"},{"issue":"5","key":"6009_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A (2015) Spatial reconstruction of single-cell gene expression data. Nat Biotechnol 33(5):495\u2013502","journal-title":"Nat Biotechnol"},{"issue":"11","key":"6009_CR21","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s43018-021-00269-7","volume":"2","author":"AR Parikh","year":"2021","unstructured":"Parikh AR, Szabolcs A, Allen JN, Clark JW, Wo JY, Raabe M, Thel H, Hoyos D, Mehta A, Arshad S, Lieb DJ, Drapek LC, Blaszkowsky LS, Giantonio BJ, Weekes CD, Zhu AX, Goyal L, Nipp RD, Dubois JS, Van Seventer EE, Foreman BE, Matlack LE, Ly L, Meurer JA, Hacohen N, Ryan DP, Yeap BY, Corcoran RB, Greenbaum BD, Ting DT, Hong TS (2021) Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nat Cancer 2(11):1124\u20131135","journal-title":"Nat Cancer"},{"issue":"1","key":"6009_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13046-022-02484-1","volume":"41","author":"A Jurj","year":"2022","unstructured":"Jurj A, Ionescu C, Berindan-Neagoe I, Braicu C (2022) The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes? J Exp Clin Cancer Res 41(1):276","journal-title":"J Exp Clin Cancer Res"},{"key":"6009_CR23","doi-asserted-by":"publisher","unstructured":"Kesh K, Gupta VK, Durden B, Garrido V, Mateo-Victoriano B, Lavania SP, Banerjee S (2020) Therapy resistance, cancer stem cells and ECM in cancer: the matrix reloaded. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12103067","DOI":"10.3390\/cancers12103067"},{"issue":"1","key":"6009_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M (2022) The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther 7(1):376","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"6009_CR25","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/1535-7163.MCT-08-1170","volume":"8","author":"AM LeBeau","year":"2009","unstructured":"LeBeau AM, Brennen WN, Aggarwal S, Denmeade SR (2009) Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin. Mol Cancer Ther 8(5):1378\u20131386","journal-title":"Mol Cancer Ther"},{"key":"6009_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40364-019-0169-8","volume":"7","author":"J Lv","year":"2019","unstructured":"Lv J, Li P (2019) Mesothelin as a biomarker for targeted therapy. Biomark Res 7:18","journal-title":"Biomark Res"},{"issue":"11","key":"6009_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307798120","volume":"121","author":"J Witten","year":"2024","unstructured":"Witten J, Hu Y, Langer R, Anderson DG (2024) Recent advances in nanoparticulate RNA delivery systems. Proc Natl Acad Sci U S A 121(11):e2307798120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6009_CR28","first-page":"759","volume":"24","author":"SJ Kuo","year":"2010","unstructured":"Kuo SJ, Chien SY, Lin C, Chan SE, Tsai HT, Chen DR (2010) Significant elevation of CLDN16 and HAPLN3 gene expression in human breast cancer. Oncol Rep 24(3):759\u2013766","journal-title":"Oncol Rep"},{"issue":"2","key":"6009_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/ejendo\/lvaf003","volume":"192","author":"Y Cai","year":"2025","unstructured":"Cai Y, Guo Y, Ma W, Cheng P, Jiang L, Shen S, Song F, Zhu L, Hu Y, Chen Y, Duan Y, Cai X, Li Q, Zheng G, Ge M (2025) A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer. Eur J Endocrinol 192(2):128\u2013140","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"6009_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113523","volume":"426","author":"MF Paes","year":"2023","unstructured":"Paes MF, Zipinotti Dos Santos D, Massariol Pimenta T, Ribeiro Junior RS, da Silva Martins B, Greco SJ, Carvalho AA, Bacchi C, Duarte C, Carvalho I, Silva IV, Azevedo Rangel LB (2023) Overexpression of CLDN16 in ovarian cancer is modulated by PI3K and PKC pathways. Exp Cell Res 426(2):113523","journal-title":"Exp Cell Res"},{"issue":"1","key":"6009_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41421-021-00368-w","volume":"8","author":"Z Mao","year":"2022","unstructured":"Mao Z, Xiao H, Shen P, Yang Y, Xue J, Yang Y, Shang Y, Zhang L, Li X, Zhang Y, Du Y, Chen CC, Guo RT, Zhang Y (2022) KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge. Cell Discov 8(1):5","journal-title":"Cell Discov"},{"issue":"6","key":"6009_CR32","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear AS, Vonderheide RH (2020) O\u2019hara, challenges and opportunities for pancreatic cancer immunotherapy. Cancer Cell 38(6):788\u2013802","journal-title":"Cancer Cell"},{"issue":"1","key":"6009_CR33","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1038\/s41467-023-39759-w","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Zhuang Y, Huang W, Wu Z, Chen Y, Shan Q, Zhang Y, Wu Z, Ding X, Qiu Z, Cui W, Wang Z (2023) Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy. Nat Commun 14(1):4106","journal-title":"Nat Commun"},{"issue":"1","key":"6009_CR34","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1038\/s41467-022-33291-z","volume":"13","author":"S Chawla","year":"2022","unstructured":"Chawla S, Rockstroh A, Lehman M, Ratther E, Jain A, Anand A, Gupta A, Bhattacharya N, Poonia S, Rai P, Das N, Majumdar A, Jayadeva G, Ahuja BG, Hollier CC, Nelson D, Sengupta (2022) Gene expression based inference of cancer drug sensitivity. Nat Commun 13(1):5680","journal-title":"Nat Commun"},{"key":"6009_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cells9041040","author":"M Sommariva","year":"2020","unstructured":"Sommariva M, Gagliano N (2020) E-cadherin in pancreatic ductal adenocarcinoma: a multifaceted actor during EMT. Cells. https:\/\/doi.org\/10.3390\/cells9041040","journal-title":"Cells"},{"issue":"10","key":"6009_CR36","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41419-022-05351-1","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Ren Y, Yang P, Wang J, Zhou H (2022) Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Cell Death Dis 13(10):897","journal-title":"Cell Death Dis"},{"key":"6009_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217699","volume":"622","author":"K Brautigam","year":"2025","unstructured":"Brautigam K, Skok K, Szymonski K, Rift CV, Karamitopoulou E (2025) Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited - exploring the \u201cSpace.\u201d Cancer Lett 622:217699","journal-title":"Cancer Lett"},{"issue":"1","key":"6009_CR38","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12967-022-03632-z","volume":"20","author":"C Yan","year":"2022","unstructured":"Yan C, Niu Y, Li F, Zhao W, Ma L (2022) System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. J Transl Med 20(1):455","journal-title":"J Transl Med"},{"issue":"1","key":"6009_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12920-023-01530-x","volume":"16","author":"JG Zhao","year":"2023","unstructured":"Zhao JG, Li YJ, Wu Y, Zhang K, Peng LJ, Chen H (2023) Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma. BMC Med Genomics 16(1):106","journal-title":"BMC Med Genomics"},{"key":"6009_CR40","volume":"2022","author":"JJ Zhang","year":"2022","unstructured":"Zhang JJ, Shao C, Yin YX, Sun Q, Li YN, Zha YW, Li MY, Hu BL (2022) Hypoxia-related signature is a prognostic biomarker of pancreatic cancer. Dis Markers 2022:6449997","journal-title":"Dis Markers"},{"key":"6009_CR41","doi-asserted-by":"publisher","first-page":"803962","DOI":"10.3389\/fimmu.2022.803962","volume":"13","author":"M Xiao","year":"2022","unstructured":"Xiao M, Liang X, Yan Z, Chen J, Zhu Y, Xie Y, Li Y, Li X, Gao Q, Feng F, Fu G, Gao Y (2022) A DNA-methylation-driven genes based prognostic signature reveals immune microenvironment in pancreatic cancer. Front Immunol 13:803962","journal-title":"Front Immunol"},{"key":"6009_CR42","doi-asserted-by":"publisher","first-page":"0173","DOI":"10.34133\/bmr.0173","volume":"29","author":"F Yu","year":"2025","unstructured":"Yu F, Zhang G, Sun J, Zhao Y, Qi Y, Han X, Ai C, Sun W, Duan J, Yu D (2025) Nanotension relief agent enhances tissue penetration by reducing solid stress in pancreatic ductal adenocarcinoma via Rho\/ROCK pathway inhibition. Biomater Res 29:0173","journal-title":"Biomater Res"},{"issue":"10","key":"6009_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203324","volume":"10","author":"X Geng","year":"2023","unstructured":"Geng X, Li L, Luo Y, Yang W, Hu J, Zhao Z, Cheng C, Zhang T, Zhang Y, Liu L, Xie Y, Li G, Liu D, Bai R, Bai X, Wang G, Chen H, Wang Y, Chen H, Sun B (2023) Tumor cell derived Lnc-FSD2-31:1 contributes to cancer-associated fibroblasts activation in pancreatic ductal adenocarcinoma progression through extracellular vesicles cargo MiR-4736. Adv Sci (Weinh) 10(10):e2203324","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"6009_CR44","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1158\/1535-7163.MCT-22-0356","volume":"21","author":"NS Akhave","year":"2022","unstructured":"Akhave NS, Biter AB, Hong DS (2022) The next generation of KRAS targeting: reasons for excitement and concern. Mol Cancer Ther 21(11):1645\u20131651","journal-title":"Mol Cancer Ther"},{"key":"6009_CR45","doi-asserted-by":"publisher","unstructured":"Farr KP, Moses D, Haghighi KS, Phillips PA, Hillenbrand CM, Chua BH (2022) Imaging modalities for early detection of pancreatic cancer: current state and future research opportunities. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14102539","DOI":"10.3390\/cancers14102539"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06009-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-06009-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06009-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T09:03:27Z","timestamp":1779786207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-06009-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6009"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-06009-9","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}